SREBP1, along with its target genes (ACC, FASN), is overexpressed in human multiform glioblastoma (EGFR mutated), and both genetic and pharmacological inhibition significantly block tumor-derived xenograft growth [178]. Here, SREBF1 is linked to neoplasm.